Compare Unichem Lab with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ALEMBIC PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB ALEMBIC PHARMA UNICHEM LAB/
ALEMBIC PHARMA
 
P/E (TTM) x -3,504.1 19.4 - View Chart
P/BV x 0.7 3.1 21.5% View Chart
Dividend Yield % 1.7 1.8 95.6%  

Financials

 UNICHEM LAB   ALEMBIC PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-21
ALEMBIC PHARMA
Mar-21
UNICHEM LAB/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs3601,150 31.3%   
Low Rs122527 23.1%   
Sales per share (Unadj.) Rs175.4274.4 63.9%  
Earnings per share (Unadj.) Rs4.956.7 8.7%  
Cash flow per share (Unadj.) Rs16.966.0 25.6%  
Dividends per share (Unadj.) Rs4.0014.00 28.6%  
Avg Dividend yield %1.71.7 99.5%  
Book value per share (Unadj.) Rs362.0260.9 138.8%  
Shares outstanding (eoy) m70.41196.56 35.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.43.1 44.9%   
Avg P/E ratio x48.914.8 330.8%  
P/CF ratio (eoy) x14.212.7 112.2%  
Price / Book Value ratio x0.73.2 20.7%  
Dividend payout %81.224.7 329.1%   
Avg Mkt Cap Rs m16,954164,818 10.3%   
No. of employees `000NANA-   
Total wages/salary Rs m3,07010,512 29.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m12,35153,931 22.9%  
Other income Rs m502875 57.4%   
Total revenues Rs m12,85354,806 23.5%   
Gross profit Rs m91114,801 6.2%  
Depreciation Rs m8441,835 46.0%   
Interest Rs m51160 32.0%   
Profit before tax Rs m51813,681 3.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1722,533 6.8%   
Profit after tax Rs m34711,148 3.1%  
Gross profit margin %7.427.4 26.9%  
Effective tax rate %33.118.5 178.8%   
Net profit margin %2.820.7 13.6%  
BALANCE SHEET DATA
Current assets Rs m13,77325,779 53.4%   
Current liabilities Rs m5,05812,808 39.5%   
Net working cap to sales %70.624.1 293.4%  
Current ratio x2.72.0 135.3%  
Inventory Days Days15523 657.9%  
Debtors Days Days74024 3,135.0%  
Net fixed assets Rs m17,34441,311 42.0%   
Share capital Rs m141393 35.8%   
"Free" reserves Rs m25,35050,883 49.8%   
Net worth Rs m25,49151,276 49.7%   
Long term debt Rs m01,999 0.0%   
Total assets Rs m31,11867,090 46.4%  
Interest coverage x11.186.4 12.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.40.8 49.4%   
Return on assets %1.316.9 7.6%  
Return on equity %1.421.7 6.3%  
Return on capital %2.226.0 8.6%  
Exports to sales %82.866.8 123.9%   
Imports to sales %14.412.7 113.6%   
Exports (fob) Rs m10,22436,020 28.4%   
Imports (cif) Rs m1,7806,845 26.0%   
Fx inflow Rs m10,22436,020 28.4%   
Fx outflow Rs m1,7806,845 26.0%   
Net fx Rs m8,44429,175 28.9%   
CASH FLOW
From Operations Rs m33114,634 2.3%  
From Investments Rs m-736-8,388 8.8%  
From Financial Activity Rs m-1,212-5,974 20.3%  
Net Cashflow Rs m-1,541262 -587.3%  

Share Holding

Indian Promoters % 50.9 69.0 73.8%  
Foreign collaborators % 0.0 0.5 -  
Indian inst/Mut Fund % 10.6 16.9 62.7%  
FIIs % 1.5 5.5 27.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.1 30.5 160.8%  
Shareholders   33,892 123,059 27.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   PANCHSHEEL ORG  NECTAR LIFESCIENCE  HIKAL.  TYCHE INDUSTRIES  MOREPEN LABS  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Related Views on News

ALEMBIC PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

Here's an analysis of the annual report of ALEMBIC PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime(Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Nov 26, 2021 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - RPG LIFE SCIENCES COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS